Assignee
I2O THERAPEUTICS INC
US·5 granted patents·11 pending applications·4 citations·filing 2021–2024
Top patents by PatentIndex Score
16 records- 0193US12233112B2Compositions comprising pharmaceutically acceptable salts of amylin analogs and uses thereofI2O THERAPEUTICS INC·Filed 2024·Granted Feb 25, 2025·2 cites·14 claims
- 0293US12233111B2Compositions comprising pharmaceutically acceptable salts of glucagon-like peptide-1 analogs and uses thereofI2O THERAPEUTICS INC·Filed 2024·Granted Feb 25, 2025·2 cites·28 claims
- 0387US2025144180A1Compositions comprising therapeutic proteins or peptides, and uses thereofI2O THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0487US2025161415A1Method of treating disease or disorder using compositions comprising pharmaceutically acceptable salts of amylin analogsI2O THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0586US12350320B2Compositions comprising pharmaceutically acceptable salts of glucagon-like peptide-1 analogs and pharmaceutically acceptable salts of amylin analogs, and uses thereofI2O THERAPEUTICS INC·Filed 2024·Granted Jul 8, 2025·0 cites·30 claims
- 0686US12337029B2Compositions comprising pharmaceutically acceptable salts of amylin analogs and uses thereofI2O THERAPEUTICS INC·Filed 2024·Granted Jun 24, 2025·0 cites·27 claims
- 0780US2024239861A1Glucagon-receptor selective polypeptides and methods of use thereofI2O THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0875US2025084142A1Long acting peptide tyrosine tyrosine (pyy) analogs and methods of useI2O THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0974US2024260993A1Implant placement and removal systemsI2O THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1073US2024100126A1Methods Comprising Continuous Administration of a GLP-1 Receptor Agonist and Co-administration of a DrugI2O THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1173US2025034225A1Long acting glucagon like polypeptide-1 (glp-1) receptor agonists and methods of useI2O THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1271US12540168B2Human amylin analog polypeptides and methods of useI2O THERAPEUTICS INC·Filed 2024·Granted Feb 3, 2026·0 cites·19 claims
- 1363US2024067716A1Ionic liquid formulations for treating inflammatory and autoimmune diseasesI2O THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1461US2024130994A1Ionic liquid formulations for treating diabetesI2O THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1553US2023158116A1Use of human amylin analog polypeptides for providing superior glycemic control to type 1 diabeticsI2O THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1651US2024228572A1Long acting glucagon receptor selective peptides and methods of useI2O THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when I2O THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →